The comparison of immunohistochemical proliferation and apoptosis markers in rectal carcinoma treated surgically or by preoperative radio-chemotherapy

Polish Journal of Pathology

Volumn 52, Issue 1-2, 2001, Pages 53-61

  Nasierowska Guttmejer, A ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE CARE; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA; STATISTICAL ANALYSIS; TUMOR REGRESSION; TUMOR VOLUME;

AGED; APOPTOSIS; BIOLOGICAL MARKERS; CARCINOMA; CELL MOVEMENT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREOPERATIVE CARE; RECTAL NEOPLASMS;

EID: 0034944146     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
2. The prognostic significance of direct extension of carcinoma of the colon and rectum
3. Clinicopathological staging and management of colorectal cancer - Introduction
4. Preoperative radiochemotherapy in rectal cancer: Long-terms results of a phase II trial
5. Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999
6. Preoperative irradiation affects functional results after surgery for rectal cancer. Results from a randomised study
7. Carcinoma of the rectum. Possible cellular predictor of metastatic potential and response to radiation therapy
8. The classification of cancer of rectum
9. College of American pathologists conference XXVI on clinical relevance of prognostic markers in solid tumors
10. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
11. Future role of the pathologist in reporting colorectal cancer
12. p53 overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma
13. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1
14. Porównanie wartości klasyfikacji Dukes'a, Astler-Coller'a, Jass'a i typu lokalizacji CEA w tkance raka odbytnicy metoda̧ analizy wieloczynnikowej
15. p53 protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma - Preliminary study
16. p53 protein accumulation and p53 gene mutation in colorectal cancer
17. Systemic heterogeneity and prognostic significance of cell proliferation in colorectal cancer
18. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
19. Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advance rectal cancers
20. Apoptosis and therapy
21. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer
22. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response and sphincter preservation
23. A multivariant analysis of pathologic prognostic indicators in large bowel cancer